Which IBD Patients Experience More Severe COVID? Research suggests immunomodulators, incomplete vaccination, and non-mRNA vaccines may play a role Jan 21, 2022
Crohn's Disease Scores With Interchangeable Humira Biosimilar "Non-medical switches" will be less of a concern when new treatment option becomes available Dec 31, 2021
Non-Invasive Nerve Stimulation Shows Promise for Younger IBD Patients Small pilot study found many children and young adults achieved clinical remission Dec 15, 2021
Year in Review: Crohn's Disease First interchangeable biosimilar approved, biologics go head-to-head Dec 15, 2021
For IBD Patients, Too Much Processed Meat May Be Deadly Study investigates diet's link to all-cause mortality, not just IBD incidence Dec 14, 2021
No Extra C. Diff Risk Observed With Vedolizumab in Ulcerative Colitis Retrospective study found no increased risk versus anti-TNF agents, but more research is needed Dec 11, 2021
Time Doesn't Heal Parents' Mental Health Wounds From Kids' IBD Dx "I was surprised" by these results, researcher says Dec 10, 2021
Biologics vs Small Molecule Drugs for UC: Which Agent Emerged on Top? The most effective drug not necessarily the safest Dec 01, 2021
JAK Inhibitor Maintenance Works in Severe Ulcerative Colitis Treatment group achieved clinical remission, met clinical secondary endpoints Oct 29, 2021
Maintenance IL-23 Blockade Yields Durable Benefit in Crohn's Disease Over 50% of patients responding to induction risankizumab maintained clinical remission at 1 year Oct 28, 2021
How Should Patients With Autoimmune Diseases Approach COVID Vaccination? Mixed messaging and a lack of tailored research leaves providers and patients in the dark Oct 22, 2021
First Interchangeable Humira Biosimilar Approved Cyltezo nabs coveted "interchangeable" status for RA, inflammatory bowel disease, and more Oct 18, 2021
IBD and Pediatric Arthritis: Exploring the Link Risk factors include enthesitis, family history, and etanercept use Sep 15, 2021
FDA Slaps Restrictions on JAK Inhibitors Over Serious Safety Risks Use for inflammatory conditions limited to those who fail on TNF blockers Sep 01, 2021
Proton Pump Inhibitors and IBD: What's the Link? Use tied to "modest" increase in risk for ulcerative colitis, Crohn's in observational studies Aug 12, 2021
COVID-19 Antibody Response in IBD Patients Quickly Wanes Canadian study emphasizes importance of vaccination in this population, researcher says Aug 04, 2021
Two Ulcerative Colitis Biologics: Same Clinical Difference? One may have additional clinical benefits, post-hoc analysis suggested Aug 02, 2021
New-Onset IBD and IL-17 Inhibitors: What Is the Risk? Underlying inflammatory disease severity should be taken into account Jul 21, 2021
Shingles Risk Slashed in IBD Patients After Vaccine Study found certain medications also showed lower incidence rates Jul 20, 2021
PURE Study Points Finger at Processed, Fatty Foods in IBD But expert serves up a heaping helping of caveats to the findings Jul 14, 2021
Adults With Obesity See Increased Risk for Crohn's Disease Growing obesity burden may contribute to rise in Crohn's incidence, researcher suggests Jul 08, 2021
Did Fecal Transplant Stop COVID in Its Tracks? Two Polish patients co-infected with C difficile saw improvements Jul 06, 2021
No Difference in Disease Markers for IBD Patients Treated With Biosimilars U.K. study shows comparable results after a year Jun 10, 2021
Tofacitinib May Cut Colectomy Risk in Hospitalized, Severe UC Small study found that patients appeared to benefit from limited-duration high-intensity therapy Jun 01, 2021
Perianal Involvement in Crohn’s Disease: How Bad for Prognosis? Poor outcomes noted, especially with severe phenotype Apr 14, 2021
Refractory IBD: The Case for Doubling Up on Drugs Meta-analysis suggests select patients can avoid surgery Apr 01, 2021
Game Changer for Ulcerative Colitis Patients Failing Anti-TNF? JAK inhibitor helped when biologic didn't Mar 12, 2021
Vedolizumab Tied to Lower Risk for Serious Infections in Ulcerative Colitis But positive association versus TNF inhibitors not seen in Crohn's disease Mar 01, 2021
JAK Inhibitor Misses Endpoint in Safety Study. Now What? Major blow to popular class of oral rheumatology drugs Jan 27, 2021
IBD and COVID: Kids Do Well International registry shows older age, comorbidities are risks; anti-TNF might protect Jan 25, 2021
For Seniors with IBD, Think Safety With Treatments Hospitalizations risks were lower with vedolizumab than TNF inhibitors Jan 24, 2021
Diets Ease Symptoms in Crohn's Both the Mediterranean and Specific Carbohydrate diets were helpful in mild to moderate disease Jan 24, 2021
Low-Dose IL-2 Shows Promise in Colitis Safety and response seen in dose-ranging ulcerative colitis trial Jan 23, 2021
IBD and COVID-19: Who Is at Risk? Worse outcomes for older patients and those with comorbidities and on steroids Dec 12, 2020
Can Some Treatments Be Stopped in IBD? With combination therapy, some patients successfully withdrew the TNF inhibitor Dec 11, 2020
Ozanimod a Winner in Ulcerative Colitis S1P receptor modulator effective for both induction and maintenance Dec 10, 2020
Smoking Worsens Crohn's Disease Smokers were more likely to have stricturing or penetrating disease, Canadian study showed Dec 10, 2020
More Evidence Early Mortality Persists in IBD Canadian study shows treatment advances haven't erased lifespan deficit Nov 09, 2020
